Conversely, in A549 cells, TLR7 or TLR8 agonists led to increased tumor cell survival, chemoresistance, and increased anti-apoptotic protein expression [60], as well as appear to increase MDSCs and reduce CD8+ T cells in mice, promoting tumor growth [34]. This evidence concerns the gene TLR7 and neoplasm.